{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:23Z","timestamp":1790712503471,"version":"4.1.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a noncommunicable inflammatory skin disease that affects approximately 2\u20133% of the world\u2019s population. Given its high impact on quality of life and the fact that a subset of patients exhibits suboptimal or secondary loss of response to current treatments, identifying new therapeutic strategies is crucial. Proliferation-associated protein 2G4 (PA2G4) is a transcription factor that has been exclusively studied in cancer research, where it promotes cell growth and enhances tumorigenesis by inhibiting apoptosis. However, its role in inflammatory skin diseases remains largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To elucidate the pathophysiological and immunological functions of PA2G4 in psoriasis, and to evaluate its potential as a therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bulk, single-cell and spatial RNA sequencing (RNAseq) combined with immunohistochemistry were used to assess PA2G4 expression in psoriatic skin compared with nonlesional control samples. Functional studies were performed in primary human keratinocytes and reconstructed human epidermis (RHE) models using the CRISPR\/Cas9-mediated knockout of PA2G4 and pharmacological inhibition of PA2G4 with the small-molecule inhibitor WS6. The regulatory effects of PA2G4 on cellular processes, such as proliferation, differentiation and survival, were investigated using RNAseq, Western blot analysis, scratch assays and annexin V staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PA2G4 was highly abundant in psoriasis, and its expression was predominantly restricted to basal proliferating keratinocytes. Its expression was positively correlated with psoriasis severity, the degree of acanthosis, neutrophil infiltration and genes that are upregulated in psoriasis. PA2G4 knockout in primary human keratinocytes activated differentiation pathways while suppressing proliferation pathways, resulting in the downregulation of proliferation- and inflammation-related genes (e.g. MKI67, IL20, VEGFA and HIF1A) and the upregulation of differentiation and cell adhesion markers (e.g. KRT6C, LCE2C and DSG4). Functionally, PA2G4 knockout reduced keratinocyte proliferation in scratch assays, attenuated interleukin-22-induced acanthosis in RHE models and promoted keratinocyte death. Pharmacological inhibition of PA2G4 using the small-molecule inhibitor WS6 similarly downregulated genes associated with proliferation and cell survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PA2G4 could promote keratinocyte hyperproliferation and survival in psoriasis, thereby critically influencing epidermal homeostasis. Therefore, inhibition of PA2G4 may represent a new treatment option for psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljag154","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:49:47Z","timestamp":1776430187000},"page":"461-472","source":"Crossref","is-referenced-by-count":1,"title":["Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4385-2193","authenticated-orcid":false,"given":"Theresa","family":"Raunegger","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2797-6867","authenticated-orcid":false,"given":"Sophia","family":"Wasserer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1363-6247","authenticated-orcid":false,"given":"Jessica","family":"Eigemann","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]},{"name":"ZAUM \u2013 Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health , Munich ,","place":["Germany"]},{"name":"Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-547X","authenticated-orcid":false,"given":"Christina","family":"Hillig","sequence":"additional","affiliation":[{"name":"Department of Computational Health, Institute of Computational Biology , Helmholtz Munich, Neuherberg ,","place":["Germany"]},{"name":"Department of Mathematics, Technical University of Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9196-5456","authenticated-orcid":false,"given":"G\u00f6rkem","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7939-3983","authenticated-orcid":false,"given":"Nils","family":"Kurzen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3203-8084","authenticated-orcid":false,"given":"Carsten B","family":"Schmidt-Weber","sequence":"additional","affiliation":[{"name":"ZAUM \u2013 Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health , Munich ,","place":["Germany"]},{"name":"German Center of Lung Research (DZL) , Neuherberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-5792","authenticated-orcid":false,"given":"Michael P","family":"Menden","sequence":"additional","affiliation":[{"name":"Department of Computational Health, Institute of Computational Biology , Helmholtz Munich, Neuherberg ,","place":["Germany"]},{"name":"Department of Biochemistry & Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne , Melbourne, VIC ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-7883","authenticated-orcid":false,"given":"Natalie","family":"Garzorz-Stark","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]},{"name":"Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institute , Stockholm ,","place":["Sweden"]},{"name":"Department of Dermatology and Venereology, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg , Freiburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-2293","authenticated-orcid":false,"given":"Inga","family":"We\u00dfels","sequence":"additional","affiliation":[{"name":"ZAUM \u2013 Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1166-2355","authenticated-orcid":false,"given":"Stefanie","family":"Eyerich","sequence":"additional","affiliation":[{"name":"ZAUM \u2013 Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health , Munich ,","place":["Germany"]},{"name":"Department of Dermatology and Venereology, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg , Freiburg ,","place":["Germany"]},{"name":"Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg , Freiburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0094-2674","authenticated-orcid":false,"given":"Kilian","family":"Eyerich","sequence":"additional","affiliation":[{"name":"Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institute , Stockholm ,","place":["Sweden"]},{"name":"Department of Dermatology and Venereology, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg , Freiburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5352-5105","authenticated-orcid":false,"given":"Tilo","family":"Biedermann","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-2836","authenticated-orcid":false,"given":"Felix","family":"Lauffer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]},{"name":"Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-4036","authenticated-orcid":false,"given":"Manja","family":"Jargosch","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Technical University of Munich , Munich ,","place":["Germany"]},{"name":"ZAUM \u2013 Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2026081811173810400_ljag154-B1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2018-214065","article-title":"Prevalence and incidence of psoriasis and psoriatic arthritis","volume":"78","author":"Sewerin","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026081811173810400_ljag154-B2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081811173810400_ljag154-B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09546630701364768","article-title":"Psoriasis comorbidities","volume":"19","author":"Gottlieb","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"2026081811173810400_ljag154-B4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"2026081811173810400_ljag154-B5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","article-title":"Interleukin 17A: toward a new understanding of psoriasis pathogenesis","volume":"71","author":"Lynde","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2026081811173810400_ljag154-B6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"2026081811173810400_ljag154-B7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1568010054022033","article-title":"Keratinocytes in inflammatory skin diseases","volume":"4","author":"Albanesi","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"2026081811173810400_ljag154-B8","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol"},{"key":"2026081811173810400_ljag154-B9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/jdv.14673","article-title":"Immune response patterns in non-communicable inflammatory skin diseases","volume":"32","author":"Eyerich","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026081811173810400_ljag154-B10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/2589977513666210707114520","article-title":"IL-23\/Th17 axis: a potential therapeutic target of psoriasis","volume":"14","author":"Sharma","year":"2022","journal-title":"Curr Drug Res Rev"},{"key":"2026081811173810400_ljag154-B11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis \u2013 results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"2026081811173810400_ljag154-B12","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med"},{"key":"2026081811173810400_ljag154-B13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"2026081811173810400_ljag154-B14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaad.2018.03.037","article-title":"Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial","volume":"79","author":"Papp","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2026081811173810400_ljag154-B15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","article-title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial","volume":"394","author":"Reich","year":"2019","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"2026081811173810400_ljag154-B16","doi-asserted-by":"crossref","first-page":"ii104","DOI":"10.1136\/annrheumdis-2012-203037","article-title":"Biomarkers in psoriasis and psoriatic arthritis","volume":"72","author":"Villanova","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026081811173810400_ljag154-B17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","article-title":"Transcription factors as targets for cancer therapy","volume":"2","author":"Darnell","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2026081811173810400_ljag154-B18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"2026081811173810400_ljag154-B19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"key":"2026081811173810400_ljag154-B20","doi-asserted-by":"crossref","first-page":"101435","DOI":"10.1016\/j.gendis.2024.101435","article-title":"Targeting MYC: multidimensional regulation and therapeutic strategies in oncology","volume":"12","author":"Duan","year":"2025","journal-title":"Genes Dis"},{"key":"2026081811173810400_ljag154-B21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.18632\/oncotarget.28722","article-title":"Targeting PCNA\/AR interaction inhibits AR-mediated signaling in castration-resistant prostate cancer cells","volume":"16","author":"Lu","year":"2025","journal-title":"Oncotarget"},{"key":"2026081811173810400_ljag154-B22","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1038\/s41467-024-48953-3","article-title":"Orthogonal proteogenomic analysis identifies the druggable PA2G4\u2013MYC axis in 3q26 AML","volume":"15","author":"Marchesini","year":"2024","journal-title":"Nat Commun"},{"key":"2026081811173810400_ljag154-B23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jare.2025.02.002","article-title":"PA2G4 in health and disease: an underestimated multifunctional regulator","volume":"78","author":"Jia","year":"2025","journal-title":"J Adv Res"},{"key":"2026081811173810400_ljag154-B24","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1073\/pnas.0602923103","article-title":"Ebp1 isoforms distinctively regulate cell survival and differentiation","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081811173810400_ljag154-B25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s12276-020-0476-z","article-title":"The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease","volume":"52","author":"Hwang","year":"2020","journal-title":"Exp Mol Med"},{"key":"2026081811173810400_ljag154-B26","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1158\/1078-0432.CCR-15-2282","article-title":"Expression and role of the ErbB3-binding protein 1 in acute myelogenous leukemic cells","volume":"22","author":"Nguyen","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026081811173810400_ljag154-B27","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.4238\/2015.May.22.20","article-title":"Ebp1 protein expression in cervical cancer tissue and its significance","volume":"14","author":"Liu","year":"2015","journal-title":"Genet Mol Res"},{"key":"2026081811173810400_ljag154-B28","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","article-title":"Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects","volume":"141","author":"Garzorz-Stark","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026081811173810400_ljag154-B29","doi-asserted-by":"crossref","first-page":"eabj3289","DOI":"10.1126\/scitranslmed.abj3289","article-title":"IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases","volume":"15","author":"Lavazais","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026081811173810400_ljag154-B30","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jid.2024.11.017","article-title":"Death-associated protein kinase 1 dampens keratinocyte necroptosis and expression of inflammatory genes in lichen planus","volume":"145","author":"Kurzen","year":"2024","journal-title":"J Invest Dermatol"},{"key":"2026081811173810400_ljag154-B31","doi-asserted-by":"crossref","first-page":"eaba6500","DOI":"10.1126\/science.aba6500","article-title":"Developmental cell programs are co-opted in inflammatory skin disease","volume":"371","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"2026081811173810400_ljag154-B32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1507\/endocrj.EJ14-0449","article-title":"WS6 induces both alpha and beta cell proliferation without affecting differentiation or viability","volume":"62","author":"Boerner","year":"2015","journal-title":"Endocr J"},{"key":"2026081811173810400_ljag154-B33","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/ja309304m","article-title":"Small-molecule inducer of beta cell proliferation identified by high-throughput screening","volume":"135","author":"Shen","year":"2013","journal-title":"J Am Chem Soc"},{"key":"2026081811173810400_ljag154-B34","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/cancers15061822","article-title":"Inhibitors of the oncogenic PA2G4\u2013MYCN protein\u2013protein interface","volume":"15","author":"Massudi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026081811173810400_ljag154-B35","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.3390\/cancers13246181","article-title":"Efficacy and synergy of small-molecule inhibitors targeting FLT3-ITD+ acute myeloid leukemia","volume":"13","author":"Bregante","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026081811173810400_ljag154-B36","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1038\/sj.onc.1207579","article-title":"EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes","volume":"23","author":"Squatrito","year":"2004","journal-title":"Oncogene"},{"key":"2026081811173810400_ljag154-B37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1054\/bjoc.1999.0981","article-title":"Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin","volume":"82","author":"Yoo","year":"2000","journal-title":"Br J Cancer"},{"key":"2026081811173810400_ljag154-B38","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1007\/s13277-015-3523-y","article-title":"EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol"},{"key":"2026081811173810400_ljag154-B39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/1471-2407-12-499","article-title":"Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance","volume":"12","author":"Sun","year":"2012","journal-title":"BMC Cancer"},{"key":"2026081811173810400_ljag154-B40","unstructured":"The Skin Atlas . Skin layers in psoriasis. Available at: https:\/\/skin.science\/dataset\/skin-layers-in-psoriasis (last accessed 23 September 2025)."},{"key":"2026081811173810400_ljag154-B41","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/nar\/gkg318","article-title":"Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases","volume":"31","author":"Zhang","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2026081811173810400_ljag154-B42","first-page":"851","article-title":"Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation","volume":"31","author":"Akinmade","year":"2007","journal-title":"Int J Oncol"},{"key":"2026081811173810400_ljag154-B43","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1093\/nar\/gki903","article-title":"The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription","volume":"33","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2026081811173810400_ljag154-B44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcp.1075","article-title":"Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation","volume":"187","author":"Xia","year":"2001","journal-title":"J Cell Physiol"},{"key":"2026081811173810400_ljag154-B45","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1535-7163.MCT-08-0526","article-title":"EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance","volume":"7","author":"Zhang","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"2026081811173810400_ljag154-B46","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.1007\/s13277-015-3625-6","article-title":"High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC)","volume":"36","author":"Gong","year":"2015","journal-title":"Tumour Biol"},{"key":"2026081811173810400_ljag154-B47","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1158\/0008-5472.CAN-10-1882","article-title":"Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors","volume":"70","author":"Kim","year":"2010","journal-title":"Cancer Res"},{"key":"2026081811173810400_ljag154-B48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yexcr.2011.08.013","article-title":"Long isoform of ErbB3 binding protein, p48, mediates protein kinase B\/Akt-dependent HDM2 stabilization and nuclear localization","volume":"318","author":"Kim","year":"2012","journal-title":"Exp Cell Res"},{"key":"2026081811173810400_ljag154-B49","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1182\/blood-2014-12-616433","article-title":"Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1","volume":"125","author":"Nguyen","year":"2015","journal-title":"Blood"},{"key":"2026081811173810400_ljag154-B50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/bjd\/ljae194","article-title":"Downregulation of lysine 2-hydroxyisobutyrylation of ErbB3 binding protein 1 at amino acid 210 promotes keratinocyte proliferation via induction of transcription initiation factor IA-mediated rRNA synthesis","volume":"192","author":"Li","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026081811173810400_ljag154-B51","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1093\/nar\/gkr278","article-title":"EBP1 and DRBP76\/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon","volume":"39","author":"Corso","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2026081811173810400_ljag154-B52","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.179.3.2005","article-title":"Identification and characterization of ErbB3-binding protein-1 as a target for immunotherapy","volume":"179","author":"Santegoets","year":"2007","journal-title":"J Immunol"},{"key":"2026081811173810400_ljag154-B53","first-page":"492","article-title":"Th17 cells in the pathogenesis of multiple sclerosis","volume":"63","author":"Juszczak","year":"2009","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"2026081811173810400_ljag154-B54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/crj.13182","article-title":"Anti-tumour effects of Keratin 6A in lung adenocarcinoma","volume":"14","author":"Xiao","year":"2020","journal-title":"Clin Respir J"},{"key":"2026081811173810400_ljag154-B55","doi-asserted-by":"crossref","first-page":"e2300246","DOI":"10.1002\/biot.202300246","article-title":"The expression pattern of cytokeratin 6a in epithelial cells of different origin in dermo-epidermal skin substitutes in vivo","volume":"19","author":"Michalak-Micka","year":"2024","journal-title":"Biotechnol J"},{"key":"2026081811173810400_ljag154-B56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbrc.2011.06.122","article-title":"Decorin gene expression and its regulation in human keratinocytes","volume":"411","author":"Velez-DelValle","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2026081811173810400_ljag154-B57","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1002\/ski2.440","article-title":"Effect of tumour necrotic factor-alpha, interleukin-17 and interleukin-22 on the expression of filaggrin-2 and hornerin: analysis of a three-dimensional psoriatic skin model","volume":"4","author":"Makino","year":"2024","journal-title":"Skin Health Dis"},{"key":"2026081811173810400_ljag154-B58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.jid.5701025","article-title":"Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes","volume":"128","author":"Sun","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2026081811173810400_ljag154-B59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cyto.2010.03.003","article-title":"Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis","volume":"51","author":"Young","year":"2010","journal-title":"Cytokine"},{"key":"2026081811173810400_ljag154-B60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12031-014-0331-6","article-title":"Upregulated expression of ebp1 contributes to Schwann cell differentiation and migration after sciatic nerve crush","volume":"54","author":"Liu","year":"2014","journal-title":"J Mol Neurosci"},{"key":"2026081811173810400_ljag154-B61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuint.2010.12.001","article-title":"p48 Ebp1 acts as a downstream mediator of Trk signaling in neurons, contributing to neuronal differentiation","volume":"58","author":"Kwon","year":"2011","journal-title":"Neurochem Int"},{"key":"2026081811173810400_ljag154-B62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11010-023-04742-y","article-title":"Effect of RNA-binding proteins on osteogenic differentiation of bone marrow mesenchymal stem cells","volume":"479","author":"Luo","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"2026081811173810400_ljag154-B63","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/sj.emboj.7601111","article-title":"Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase","volume":"25","author":"Ahn","year":"2006","journal-title":"EMBO J"},{"key":"2026081811173810400_ljag154-B64","first-page":"1283","volume-title":"Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48","author":"Ko","year":"2015"},{"key":"2026081811173810400_ljag154-B65","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1471-4159.2006.04313.x","article-title":"Protein kinase C-delta phosphorylates Ebp1 and prevents its proteolytic degradation, enhancing cell survival","volume":"100","author":"Liu","year":"2007","journal-title":"J Neurochem"},{"key":"2026081811173810400_ljag154-B66","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1158\/0008-5472.CAN-19-1112","article-title":"Drugging MYCN oncogenic signaling through the MYCN\u2013PA2G4 binding interface","volume":"79","author":"Koach","year":"2019","journal-title":"Cancer Res"},{"key":"2026081811173810400_ljag154-B67","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"2026081811173810400_ljag154-B68","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cells14181422","article-title":"PA2G4 functions as a cofactor for MYC family oncoproteins in MYC-driven malignancies","volume":"14","author":"Krishan","year":"2025","journal-title":"Cells"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag154\/68117118\/ljag154.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag154\/68117118\/ljag154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag154\/68117118\/ljag154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:23:42Z","timestamp":1787066622000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/195\/3\/461\/8659420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":68,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,20]]},"published-print":{"date-parts":[[2026,8,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag154","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,4,20]]}}}